|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
5 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares | |||
| General and administrative expenses paid by related party | |||
| Depreciation and amortization | |||
| Loss on disposal of fixed assets | |||
| Asset impairment charge | |||
| Stock-based compensation | |||
| Amortization of debt discount and issuance costs | |||
| Accretion of debt end of term charge and PIK interest | |||
| Gain on debt extinguishment | |||
| Loss on valuation of derivative and warrant liabilities | |||
| Others | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accounts payable | |||
| Accrued expenses | |||
| Accounts receivable | |||
| Inventory | |||
| Prepaid expenses and other current assets | |||
| Deferred cost of goods sold | |||
| Operating lease right-of-use assets and liabilities | |||
| Other assets | |||
| Accounts payable and accrued liabilities | |||
| Deferred revenue, current and non-current | |||
| Other non-current liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Cash deposited in Trust Account | |||
| Purchase of investments | |||
| Proceeds from maturities of investments | |||
| Purchase of property and equipment | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from note payable to related party | |||
| Proceeds received from initial public offering, gross | |||
| Proceeds received from private placement | |||
| Offering costs paid | |||
| Repayment of note payable to related parties | |||
| Merger and PIPE financing | |||
| Payment of tax withholding obligations on earnout shares | |||
| Proceeds from debt, net of issuance costs | |||
| Repayment of debt | |||
| Repayment of finance obligation | |||
| Proceeds from government grants | |||
| Proceeds from (repayment of) government grants | |||
| Proceeds from exercise of stock options and warrants | |||
| Proceeds from employee stock purchase plan | |||
| Other financing activities | |||
| Net cash provided by financing activities | |||
| Net increase (decrease) in cash and cash equivalents, and restricted cash | |||
| Cash - beginning of the period | |||
| Cash - ending of the period | |||
| Offering costs included in accrued expenses | |||
| Offering costs included in note payable – related party | |||
| Deferred underwriting commissions | |||
| Original Value of Class A ordinary shares subject to possible redemption | |||
| Change in value of Class A ordinary shares subject to possible redemption | |||
| Cash and cash equivalents, and restricted cash at the beginning of year | |||
| Cash and cash equivalents, and restricted cash at the end of year | |||
| Supplemental disclosures of cash flow information: | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
| Non-cash investing and financing activity: | |||
| Issuance of warrants in connection with debt borrowing | |||
| Assets acquired through accounts payable and accrued liabilities | |||
| Non-cash transfer of vehicles from inventory to internal use | |||
| Non-cash transfer of leased assets to inventory | |||
| Reclassification of Convertible Notes warrants liability upon exercise | |||
| Reclassification of remaining Convertible Notes warrants liability upon the reverse recapitalization | |||
| Reclassification of derivative liability upon the reverse recapitalization | |||
| Conversion of preferred stock into common stock | |||
| Cashless warrant exercise | |||
| Non-cash long-term investment |
Loading...